Medinet CoTSE:2370 41 PB Ratio is 1.94 as of Jul. 13, 2026, which is 19% below its 10-year median of 2.39. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,231 Biotechnology companies, Medinet Co ranks better than 64.74% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-13), Medinet Co's share price is 円25.00. Medinet Co's Book Value per Share for the quarter that ended in Mar. 2026 was 円12.89. Hence, Medinet Co's PB Ratio of today is 1.94.
Good Sign:
Medinet Co Ltd stock PB Ratio (=1.94) is close to 1-year low of 1.86.
The historical rank and industry rank for Medinet Co's PB Ratio or its related term are showing as below:
TSE:2370'
s PB Ratio Range Over the Past 10 Years
Min: 1.48 Med: 2.39 Max: 5.43
Current: 1.94
During the past 13 years, Medinet Co's highest PB Ratio was 5.43. The lowest was 1.48. And the median was 2.39.
TSE:2370's PB Ratio is ranked better than 64.74% of 1231
companies
in the Biotechnology industry
Industry Median: 2.93
vs TSE:2370: 1.94
During the past 12 months, Medinet Co's average Book Value Per Share Growth Rate was -23.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -13.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -13.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medinet Co was 24.90% per year. The lowest was -30.60% per year. And the median was -10.35% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medinet Co PB Ratio Related Terms
Medinet Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Medinet Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Medinet Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medinet Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Medinet Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medinet Co (TSE:2370) has a PB Ratio of 1.94 as of Jul. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medinet Co and its competitors. This is 19% below median its historical median of 2.39. Over the past decade, Medinet Co's PB Ratio has ranged from 1.48 to 5.43. According to the industry distribution chart, Medinet Co ranks #434 out of 1231 companies in the Biotechnology industry, placing it in the top 35.3%.
Is Medinet Co's PB Ratio too high?
Medinet Co's current PB Ratio of 1.94 is 19% below median its 10-year median of 2.39. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 5.43. The Biotechnology industry median PB Ratio is 2.93. Medinet Co's value of 1.94 is 33.8% below this industry median. Based on the distribution chart, Medinet Co ranks #434 out of 1231 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #434 out of 1231 companies for PB Ratio. This puts Medinet Co in the upper half of its industry. The industry median PB Ratio is 2.93. Medinet Co's value of 1.94 is 33.8% below this benchmark. Historically, Medinet Co's own PB Ratio has ranged from 1.48 to 5.43 over the past decade. While the company's 10-year median is 2.39 vs. the industry median of 2.93, Medinet Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.93, based on 1,231 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinet Co's current PB Ratio of 1.94 is 33.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medinet Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinet Co's current PB Ratio is 1.94, which is 19% below median its own 10-year median of 2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current PB Ratio is 1.94, which is 19% below median its 10-year median of 2.39 and 33.8% below the Biotechnology industry median of 2.93. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current PB Ratio is 1.94 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
PB Ratio: 1.94 (19% below median its 10-year median of 2.39)
GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
Industry Position: 33.8% below the Biotechnology median (#434 of 1231)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score
Get the complete analysis for TSE:2370
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
